These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 24784220)
1. Agonist-bound structure of the human P2Y12 receptor. Zhang J; Zhang K; Gao ZG; Paoletta S; Zhang D; Han GW; Li T; Ma L; Zhang W; Müller CE; Yang H; Jiang H; Cherezov V; Katritch V; Jacobson KA; Stevens RC; Wu B; Zhao Q Nature; 2014 May; 509(7498):119-22. PubMed ID: 24784220 [TBL] [Abstract][Full Text] [Related]
2. Structure of the human P2Y12 receptor in complex with an antithrombotic drug. Zhang K; Zhang J; Gao ZG; Zhang D; Zhu L; Han GW; Moss SM; Paoletta S; Kiselev E; Lu W; Fenalti G; Zhang W; Müller CE; Yang H; Jiang H; Cherezov V; Katritch V; Jacobson KA; Stevens RC; Wu B; Zhao Q Nature; 2014 May; 509(7498):115-8. PubMed ID: 24670650 [TBL] [Abstract][Full Text] [Related]
3. Modeling ligand recognition at the P2Y12 receptor in light of X-ray structural information. Paoletta S; Sabbadin D; von Kügelgen I; Hinz S; Katritch V; Hoffmann K; Abdelrahman A; Straßburger J; Baqi Y; Zhao Q; Stevens RC; Moro S; Müller CE; Jacobson KA J Comput Aided Mol Des; 2015 Aug; 29(8):737-56. PubMed ID: 26194851 [TBL] [Abstract][Full Text] [Related]
4. Two disparate ligand-binding sites in the human P2Y1 receptor. Zhang D; Gao ZG; Zhang K; Kiselev E; Crane S; Wang J; Paoletta S; Yi C; Ma L; Zhang W; Han GW; Liu H; Cherezov V; Katritch V; Jiang H; Stevens RC; Jacobson KA; Zhao Q; Wu B Nature; 2015 Apr; 520(7547):317-21. PubMed ID: 25822790 [TBL] [Abstract][Full Text] [Related]
5. Competitive mode and site of interaction of ticagrelor at the human platelet P2Y12 -receptor. Hoffmann K; Lutz DA; Straßburger J; Baqi Y; Müller CE; von Kügelgen I J Thromb Haemost; 2014 Nov; 12(11):1898-905. PubMed ID: 25186974 [TBL] [Abstract][Full Text] [Related]
8. Identification of determinants required for agonistic and inverse agonistic ligand properties at the ADP receptor P2Y12. Schmidt P; Ritscher L; Dong EN; Hermsdorf T; Cöster M; Wittkopf D; Meiler J; Schöneberg T Mol Pharmacol; 2013 Jan; 83(1):256-66. PubMed ID: 23093496 [TBL] [Abstract][Full Text] [Related]
9. Modeling Membrane Protein-Ligand Binding Interactions: The Human Purinergic Platelet Receptor. Greene D; Botello-Smith WM; Follmer A; Xiao L; Lambros E; Luo R J Phys Chem B; 2016 Dec; 120(48):12293-12304. PubMed ID: 27934233 [TBL] [Abstract][Full Text] [Related]
10. Structure of the human P2Y₁₂ receptor in complex with an antithrombotic drug. Du B; Liu M Sci China Life Sci; 2014 Jun; 57(6):645-6. PubMed ID: 24801571 [No Abstract] [Full Text] [Related]
11. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors. Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464 [TBL] [Abstract][Full Text] [Related]
12. Optimization of P2Y Kong D; Xue T; Guo B; Cheng J; Liu S; Wei J; Lu Z; Liu H; Gong G; Lan T; Hu W; Yang Y J Med Chem; 2019 Mar; 62(6):3088-3106. PubMed ID: 30843696 [TBL] [Abstract][Full Text] [Related]
13. Identification of a new dysfunctional platelet P2Y12 receptor variant associated with bleeding diathesis. Lecchi A; Razzari C; Paoletta S; Dupuis A; Nakamura L; Ohlmann P; Gachet C; Jacobson KA; Zieger B; Cattaneo M Blood; 2015 Feb; 125(6):1006-13. PubMed ID: 25428217 [TBL] [Abstract][Full Text] [Related]
14. G protein-coupled purinergic P2Y receptor oligomerization: Pharmacological changes and dynamic regulation. Guo X; Li Q; Pi S; Xia Y; Mao L Biochem Pharmacol; 2021 Oct; 192():114689. PubMed ID: 34274353 [TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of action for reversible P2Y12 antagonists. Liu H; Ge H; Peng Y; Xiao P; Xu J Biophys Chem; 2011 May; 155(2-3):74-81. PubMed ID: 21440362 [TBL] [Abstract][Full Text] [Related]
16. Inverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor. Aungraheeta R; Conibear A; Butler M; Kelly E; Nylander S; Mumford A; Mundell SJ Blood; 2016 Dec; 128(23):2717-2728. PubMed ID: 27694321 [TBL] [Abstract][Full Text] [Related]
17. Comparison of three GPCR structural templates for modeling of the P2Y12 nucleotide receptor. Deflorian F; Jacobson KA J Comput Aided Mol Des; 2011 Apr; 25(4):329-38. PubMed ID: 21461952 [TBL] [Abstract][Full Text] [Related]
18. Receptor homodimerization plays a critical role in a novel dominant negative P2RY12 variant identified in a family with severe bleeding. Mundell SJ; Rabbolini D; Gabrielli S; Chen Q; Aungraheeta R; Hutchinson JL; Kilo T; Mackay J; Ward CM; Stevenson W; Morel-Kopp MC J Thromb Haemost; 2018 Jan; 16(1):44-53. PubMed ID: 29117459 [TBL] [Abstract][Full Text] [Related]
19. State of affairs: Design and structure-activity relationships of reversible P2Y12 receptor antagonists. Zetterberg F; Svensson P Bioorg Med Chem Lett; 2016 Jun; 26(12):2739-2754. PubMed ID: 27133596 [TBL] [Abstract][Full Text] [Related]
20. GPR17: molecular modeling and dynamics studies of the 3-D structure and purinergic ligand binding features in comparison with P2Y receptors. Parravicini C; Ranghino G; Abbracchio MP; Fantucci P BMC Bioinformatics; 2008 Jun; 9():263. PubMed ID: 18533035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]